Sepsis Diagnostics Market By Reports and Data

Views:
 
Category: Entertainment
     
 

Presentation Description

No description available.

Comments

Presentation Transcript

Slide1:

Sepsis Diagnostics Market To Reach USD 772.1 Million By 2026

Increasing awareness across the globe, growing geriatric population, continuous growth in population, increasing environmental pollution and increased investments in the healthcare sector coupled with increased adoption of advanced technologies by the healthcare professionals key factors contributing to high CAGR of Sepsis Diagnostics during forecast period. Market Size – USD 385.0 Million in 2018, Market Growth - CAGR of 9%, Market Trends – Growing awareness and research in diagnosis of Sepsis. According to the current analysis of Reports and Data, the global Sepsis Diagnostics market was valued at USD 385.0 million in 2018 and is expected to reach USD 772.1 million by the year 2026, at a CAGR of 9.0%. Sepsis is one of the significant challenges faced by hospitals. Sepsis is a medical condition caused by an overactive immune response to an infection. The immune system releases chemicals for protecting the body from disease; however, excess of these chemicals causes other severe conditions, including inflammation, blood clots, and leaky blood vessels. The unsteady blood flow causes a lack of proper blood flow to all the body organs leading to organ failure and in extreme conditions, septic shock. Sepsis is most common in infants, pregnant women, sick people, and the old population. Thus, a rise in geriatric population has led to an increase in the sepsis diagnosis activities.:

Increasing awareness across the globe, growing geriatric population, continuous growth in population, increasing environmental pollution and increased investments in the healthcare sector coupled with increased adoption of advanced technologies by the healthcare professionals key factors contributing to high CAGR of Sepsis Diagnostics during forecast period. Market Size – USD 385.0 Million in 2018, Market Growth - CAGR of 9%, Market Trends – Growing awareness and research in diagnosis of Sepsis. According to the current analysis of Reports and Data, the global Sepsis Diagnostics market was valued at USD 385.0 million in 2018 and is expected to reach USD 772.1 million by the year 2026, at a CAGR of 9.0%. Sepsis is one of the significant challenges faced by hospitals. Sepsis is a medical condition caused by an overactive immune response to an infection. The immune system releases chemicals for protecting the body from disease; however, excess of these chemicals causes other severe conditions, including inflammation, blood clots, and leaky blood vessels. The unsteady blood flow causes a lack of proper blood flow to all the body organs leading to organ failure and in extreme conditions, septic shock. Sepsis is most common in infants, pregnant women, sick people, and the old population. Thus, a rise in geriatric population has led to an increase in the sepsis diagnosis activities. www.reportsanddata.com Market Summary

Slide3:

Further key findings from the report suggest Sepsis Diagnostics market is growing at a CAGR of 9% in Asia Pacific followed by North America and Europe with 8.7 % and 8.8% CAGR respectively. High prevalence of chronic diseases is expected to drive the market growth. As of 2018, Blood Culture technology segment dominated Sepsis Diagnostics which holds 37.3% of the global market. North America regional market is the chief revenue generating source for this product segment, followed by Europe and Asia-Pacific regions. The market of sepsis diagnostic is driven by the increase in sepsis cases, caused by gram-positive bacteria. The gram-positive bacterium has led to an increase in the number of patients with severe sepsis conditions and septic shock. Introduction of new products for diagnostic purposes is expected to majorly drive the market for sepsis diagnosis in the coming years. For example, VIDAS B•R•A•H•M•S PCT, an automated assay measuring procalcitonin (PCT) levels launched by a leading in vitro diagnostic company, BioMérieux , enables the healthcare professions to take important decisions related to the recommendation of antibiotics for the patient.

Slide4:

www.reportsanddata.com Market Summary Key Players: For the purpose of this report, Reports and Data has segmented the Sepsis Diagnostics market on the basis of product type, technology type, pathogens type, method type, test type, end use, and region: Product Type (Revenue, USD Million; 2016–2026) Blood Culture Media Assays & Reagents Instruments Software Others BioMérieux (France), Danaher (US), Becton, Dickinson and Company (US), Roche (Switzerland), and Abbott (US), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), CytoSorbents (US), and EKF (US) Segmentation : To look at the PDF Sample Report and get 30 minutes of a free consultation @ https:// www.reportsanddata.com/sample-enquiry-form/2234

Slide5:

www.reportsanddata.com Market Summary Technology Type (Revenue, USD Million; 2016–2026) Microbiology Molecular Diagnostics Immunoassays Flow Cytometry Microfluidics Biomarkers Pathogens Type (Revenue, USD Million; 2016–2026) Bacterial Sepsis Gram-Positive Bacteria Gram-Negative Bacteria Fungal Sepsis Others Method   Type (Revenue, USD Million; 2016–2026 ) Conventional Diagnostic Automatic Diagnostic Grab Your Report at an Impressive Discount! Please Click Here : https:// www.reportsanddata.com/make-enquiry-form/2234

Slide6:

www.reportsanddata.com The report emphasizes the following key questions: Q.1.What are the most lucrative and promising growth prospects for the market ? Q.2.Which sectors are expected to deliver a high growth rate and which industry aspects come into play in this advancement ? Q.3.Which geographies are estimated to exhibit the highest growth and the underlying causes ? Q.4.Which factors are impacting the future of the market and what are the driving factors ? Q.5.What are the hurdles and challenges curtailing the industry’s growth in the forecast period?

Slide7:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: [email protected] About Us

authorStream Live Help